Key result
NOS inhibition in septic shock is linked to corrected vasoplegic hemodynamics without worsening tissue oxygenation.
Why the study?
The effects of nitric oxide synthase inhibition on tissue oxygenation and hemodynamics in severe septic shock were not well characterized.
Does NOS inhibition improve hemodynamics without deteriorating tissue oxygenation in patients with severe septic shock?
Observational (n=8)
Does NOS inhibition improve hemodynamics without deteriorating tissue oxygenation in patients with severe septic shock?
NOS inhibition in severe septic shock corrects vasoplegic hemodynamic disturbances and allows weaning of adrenergic support without deteriorating tissue oxygenation.
Answers are grounded in this paper and cite their sources.
Hypothesis-generating for NOS inhibition in refractory septic shock; prospective trials needed before clinical adoption.
The objective of the study was to evaluate the tissue oxygenation and hemodynamic effects of NOS inhibition in clinical severe septic shock. Eight patients with septic shock refractory to volume loading and high level of adrenergic support were prospectively enrolled in the study. Increasing doses of NOS inhibitors [N(G)-nitro-L-arginine-methyl ester (L-NAME) or N(G)-monomethyl-L-arginine (L-NMMA)] were administered as i.v. bolus until a peak effect = 10 mmHg on mean blood pressure was obtained or until side effects occurred. If deemed clinically appropriate, a continuous infusion of L-NAME was instituted and adrenergic support weaning attempted. The bolus administration of NOS inhibitors transiently increased mean blood pressure by 10 mm Hg in all patients. Seven out of eight patients received an L-NAME infusion, associated over 24 h with a progressive decline in cardiac index (P < 0.001) and an increase in systemic vascular resistance (P < 0.01). Partial or total adrenergic support weaning was rapidly possible in 6/8 patients. Oxygen transport decreased (P < 0.001), but oxygen consumption remained unchanged in those patients in whom it could be measured by indirect calorimetry (5/8). Blood lactate and the difference between tonometric gastric and arterial PCO2 remained unchanged. There were 4/8 ICU survivors. We conclude that nitric oxide synthase inhibition in severe septic shock was followed with a progressive correction of the vasoplegic hemodynamic disturbances with finally normalization of cardiac output and systemic vascular resistances without any demonstrable deterioration in tissue oxygenation.
No takes yet. Share an insight, caveat, or question.
Broccard et al. (2000) conducted an observational in severe septic shock (n=8). NOS inhibitors (L-NAME or L-NMMA) was evaluated on cardiac index (p=<0.001). NOS inhibition in severe septic shock corrected vasoplegic hemodynamics, decreasing cardiac index and increasing systemic vascular resistance without worsening tissue oxygenation.
Synapse has enriched 10 related papers. Consider them for comparative context: